Aktis Oncology, Inc.
AKTS
$21.62
-$0.03-0.14%
NASDAQ
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 297.17M | ||||
| Total Receivables | 1.10M | ||||
| Inventory | -- | ||||
| Prepaid Expenses | 2.59M | ||||
| Finance Division Loans and Leases Current | -- | ||||
| Total Finance Division Other Current Assets | -- | ||||
| Other Current Assets | -- | ||||
| Total Current Assets | 300.85M | ||||
|
|
|||||
| Total Current Assets | 300.85M | ||||
| Net Property, Plant & Equipment | 20.87M | ||||
| Long-term Investments | -- | ||||
| Goodwill | -- | ||||
| Total Other Intangibles | -- | ||||
| Finance Div Loans & Leases LT | -- | ||||
| Total Finance Div Other LT Assets | -- | ||||
| Total Other Assets | 4.46M | ||||
| Total Assets | 326.18M | ||||
|
|
|||||
| Total Accounts Payable | 1.92M | ||||
| Total Accrued Expenses | 6.33M | ||||
| Short-term Debt | -- | ||||
| Current Portion of Long-Term Debt/Capital Leases | -- | ||||
| Finance Division Debt Current | 1.30M | ||||
| Total Finance Division Other Current Liabilities | 9.28M | ||||
| Total Other Current Liabilities | 9.28M | ||||
| Total Current Liabilities | 18.82M | ||||
|
|
|||||
| Total Current Liabilities | 18.82M | ||||
| Long-Term Debt | -- | ||||
| Short-term Debt | -- | ||||
| Capital Leases | 10.71M | ||||
| Finance Division Debt Non Current | -- | ||||
| Total Finance Division Other Non Current Liabilities | -- | ||||
| Total Other Liabilities | 51.04M | ||||
| Total Liabilities | 80.58M | ||||
|
|
|||||
| Common Stock & APIC | 4.91M | ||||
| Retained Earnings | -92.83M | ||||
| Treasury Stock & Other | 124.00K | ||||
| Total Common Equity | -87.80M | ||||
|
|
|||||
| Preferred Stock Redeemable | -- | ||||
| Preferred Stock Non Redeemable | -- | ||||
| Preferred Stock Convertible | 333.41M | ||||
| Preferred Stock, Others | -- | ||||
| Total Preferred Equity | 333.41M | ||||
|
|
|||||
| Total Common Equity | -87.80M | ||||
| Total Preferred Equity | 333.41M | ||||
| Total Minority Interest | -- | ||||
| Total Equity | 245.61M | ||||
|
|
|||||